ARTICLE | Company News
Axcan, Aventis GI product deal
October 9, 2003 7:00 AM UTC
Axcan (TSE:AXC; AXCA) acquired North American rights from AVE to duodenal ulcer drug Carafate (Sulcrate in Canada), irritable bowel syndrome drug Bentyl (Bentylol in Canada) and hemorrhoidal drug Proc...